See more : Spree Acquisition Corp. 1 Limited (SHAP-UN) Income Statement Analysis – Financial Results
Complete financial analysis of Meghmani Finechem Limited (MFL.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Meghmani Finechem Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- Public Joint Stock Company Territorial Generation Company No. 14 (TGKN.ME) Income Statement Analysis – Financial Results
- Muehlhan AG (M4N.DE) Income Statement Analysis – Financial Results
- Avon Protection plc (AVON.L) Income Statement Analysis – Financial Results
- Bull Trading and Investment Ltd. (BULL.TA) Income Statement Analysis – Financial Results
- Bold Ventures Inc. (BVLDF) Income Statement Analysis – Financial Results
Meghmani Finechem Limited (MFL.NS)
About Meghmani Finechem Limited
Meghmani Finechem Limited manufactures and sells chlor-alkali and its derivatives in India. The company offers caustic soda, chlorine, hydrogen, caustic potash, chloromethanes, and hydrogen peroxide. It serves refineries, paper and pulp, fluoropolymers, soap and detergent, textile, dyes and pigments, pharmaceuticals, agrochemicals, alumina, PU foams, paints, PTEE pipes, heat resistant pipes, refrigerant gas, water treatment, and electronic industries. The company was incorporated in 2007 and is based in Ahmedabad, India.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 21.88B | 15.50B | 8.26B | 6.10B | 7.10B | 5.97B |
| Cost of Revenue | 11.15B | 8.01B | 4.12B | 2.92B | 2.69B | 2.49B |
| Gross Profit | 10.74B | 7.48B | 4.13B | 3.18B | 4.41B | 3.49B |
| Gross Profit Ratio | 49.06% | 48.29% | 50.06% | 52.12% | 62.12% | 58.37% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 47.12M | 38.47M | 19.82M | 18.12M | 13.59M |
| Selling & Marketing | 0.00 | 170.19M | 44.98M | 46.84M | 67.64M | 19.64M |
| SG&A | 0.00 | 217.31M | 83.45M | 66.65M | 85.76M | 33.22M |
| Other Expenses | 79.84M | 9.89M | 5.85M | 75.00K | 1.73B | 0.00 |
| Operating Expenses | 4.94B | 3.25B | 2.26B | 1.67B | 1.82B | 1.48B |
| Cost & Expenses | 16.08B | 11.26B | 6.38B | 4.59B | 4.51B | 3.97B |
| Interest Income | 0.00 | 1.59M | 1.48M | 1.39M | 14.00M | 2.90M |
| Interest Expense | 655.02M | 319.05M | 308.96M | 78.02M | 25.14M | 77.45M |
| Depreciation & Amortization | 1.09B | 859.06M | 735.45M | 443.02M | 540.99M | 552.72M |
| EBITDA | 6.97B | 5.00B | 2.59B | 1.86B | 3.01B | 2.55B |
| EBITDA Ratio | 31.85% | 32.28% | 31.35% | 30.56% | 42.37% | 42.63% |
| Operating Income | 5.88B | 4.24B | 1.88B | 1.51B | 2.59B | 1.99B |
| Operating Income Ratio | 26.87% | 27.33% | 22.74% | 24.82% | 36.49% | 33.37% |
| Total Other Income/Expenses | -655.02M | -401.59M | -269.28M | -104.43M | -167.86M | -41.13M |
| Income Before Tax | 5.22B | 3.83B | 1.61B | 1.41B | 2.42B | 1.95B |
| Income Before Tax Ratio | 23.87% | 24.74% | 19.48% | 23.11% | 34.12% | 32.69% |
| Income Tax Expense | 1.69B | 1.31B | 600.19M | 289.95M | 594.84M | 396.94M |
| Net Income | 3.53B | 2.53B | 1.01B | 1.12B | 1.83B | 1.55B |
| Net Income Ratio | 16.14% | 16.31% | 12.21% | 18.36% | 25.74% | 26.04% |
| EPS | 85.03 | 60.84 | 24.27 | 26.95 | 44.00 | 37.42 |
| EPS Diluted | 85.03 | 60.84 | 17.26 | 26.95 | 44.00 | 37.42 |
| Weighted Avg Shares Out | 41.55M | 41.55M | 58.43M | 41.55M | 41.55M | 41.55M |
| Weighted Avg Shares Out (Dil) | 41.55M | 41.55M | 58.43M | 41.55M | 41.55M | 41.55M |
Source: https://incomestatements.info
Category: Stock Reports